{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:59:49Z","timestamp":1778288389994,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Victorian Cancer Agency (VCA)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.vaccine.2014.05.041","type":"journal-article","created":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T02:16:08Z","timestamp":1400724968000},"page":"4082-4088","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["How best to interpret mixed human papillomavirus genotypes in high-grade cervical intraepithelial neoplasia lesions"],"prefix":"10.1016","volume":"32","author":[{"given":"Emma T.","family":"Callegari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepehr N.","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Pyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Saville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa M.","family":"Cornall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia M.L.","family":"Brotherton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne M.","family":"Garland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.05.041_bib0005","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0010","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.vaccine.2006.05.111","article-title":"Chapter 2: The burden of HPV-related cancers","volume":"24","author":"Parkin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/14635240.2006.10708080","article-title":"H.P.V. D.N.A. testing: potential clinical applications","volume":"44","author":"Garland","year":"2006","journal-title":"Int J Health Promot Educ"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0020","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine","volume":"56","author":"Markowitz","year":"2007","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.vaccine.2006.05.031","article-title":"Chapter 6: Epidemiology and transmission dynamics of genital HPV infection","volume":"24S3:","author":"Burchell","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0030","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/aje\/kwf180","article-title":"Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students","volume":"157","author":"Winer","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1155\/2007\/136906","article-title":"HPV infections in adolescents","volume":"23","author":"Moscicki","year":"2007","journal-title":"Dis Markers"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcv.2004.12.008","article-title":"The epidemiology of human papillomavirus infections","volume":"32","author":"Baseman","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0050","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1469-0691.2009.03032.x","article-title":"Human papilloma viruses and cancer in the post-vaccine era","volume":"15","author":"Galani","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0055","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.vaccine.2006.06.018","article-title":"Updating the natural history of HPV and anogenital cancer","volume":"24","author":"Moscicki","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0060","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1086\/315805","article-title":"Concurrent and sequential acquisition of different genital human papillomavirus types","volume":"182","author":"Thomas","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0065","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jcp.57.1.68","article-title":"Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population","volume":"57","author":"Cuschieri","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0070","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1741-7015-9-104","article-title":"Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program","volume":"9","author":"Garland","year":"2011","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0075","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1525-1438.2006.00453.x","article-title":"Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Melbourne, Australia","volume":"16","author":"Stevens","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0080","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/path.3970","article-title":"One virus, one lesion\u2014individual components of CIN lesions contain a specific HPV type","volume":"227","author":"Quint","year":"2011","journal-title":"J Pathol"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0085","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/bjc.1993.152","article-title":"Human papillomavirus, herpes simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark)\u2014a second look","volume":"67","author":"Kjaer","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0090","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/mp.53.2.64","article-title":"Laser capture microscopy","volume":"53","author":"Curran","year":"2000","journal-title":"Mol Pathol"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0095","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1126\/science.274.5289.998","article-title":"Laser capture microdissection","volume":"274","author":"Emmert Buck","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/1471-2407-13-296","article-title":"Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study)","volume":"13","author":"Young","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0105","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.28228","article-title":"Anal and perianal squamous carcinomas and high-grade intraepithelial lesions exclusively associated with \u201clow-risk\u201d HPV genotypes 6 and 11","author":"Cornall","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1155\/2007\/874795","article-title":"Histopathology and cytopathology of cervical cancer","volume":"23","author":"Jenkins","year":"2007","journal-title":"Dis Markers"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0115","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nprot.2006.85","article-title":"Laser-capture microdissection","volume":"1","author":"Espina","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/path.855","article-title":"Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF10 PCR and HPV genotyping","volume":"194","author":"Quint","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0125","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1128\/JCM.37.8.2508-2517.1999","article-title":"Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus","volume":"37","author":"Kleter","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.virol.2009.05.006","article-title":"Laser capture microdissection of cervical human papillomavirus infections: copy number of the virus in cancerous and normal tissue and heterogeneous DNA methylation","volume":"390","author":"Kalantari","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0135","doi-asserted-by":"crossref","first-page":"E946","DOI":"10.1002\/ijc.27532","article-title":"Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16","volume":"131","author":"van der Marel","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0140","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","author":"The FUTURE.II Study Group","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0145","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.05.041_bib0150","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1158\/1055-9965.EPI-09-0067","article-title":"Human papillomavirus infections and vulvar disease development","volume":"18","author":"Garland","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14007087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14007087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T19:51:08Z","timestamp":1597866668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14007087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":30,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0264410X14007087"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How best to interpret mixed human papillomavirus genotypes in high-grade cervical intraepithelial neoplasia lesions","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}